Cargando…

COVID-19 pathophysiology: A review

In December 2019, a novel coronavirus, now named as SARS-CoV-2, caused a series of acute atypical respiratory diseases in Wuhan, Hubei Province, China. The disease caused by this virus was termed COVID-19. The virus is transmittable between humans and has caused pandemic worldwide. The number of dea...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuki, Koichi, Fujiogi, Miho, Koutsogiannaki, Sophia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169933/
https://www.ncbi.nlm.nih.gov/pubmed/32325252
http://dx.doi.org/10.1016/j.clim.2020.108427
_version_ 1783523821471399936
author Yuki, Koichi
Fujiogi, Miho
Koutsogiannaki, Sophia
author_facet Yuki, Koichi
Fujiogi, Miho
Koutsogiannaki, Sophia
author_sort Yuki, Koichi
collection PubMed
description In December 2019, a novel coronavirus, now named as SARS-CoV-2, caused a series of acute atypical respiratory diseases in Wuhan, Hubei Province, China. The disease caused by this virus was termed COVID-19. The virus is transmittable between humans and has caused pandemic worldwide. The number of death tolls continues to rise and a large number of countries have been forced to do social distancing and lockdown. Lack of targeted therapy continues to be a problem. Epidemiological studies showed that elder patients were more susceptible to severe diseases, while children tend to have milder symptoms. Here we reviewed the current knowledge about this disease and considered the potential explanation of the different symptomatology between children and adults.
format Online
Article
Text
id pubmed-7169933
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71699332020-04-21 COVID-19 pathophysiology: A review Yuki, Koichi Fujiogi, Miho Koutsogiannaki, Sophia Clin Immunol Article In December 2019, a novel coronavirus, now named as SARS-CoV-2, caused a series of acute atypical respiratory diseases in Wuhan, Hubei Province, China. The disease caused by this virus was termed COVID-19. The virus is transmittable between humans and has caused pandemic worldwide. The number of death tolls continues to rise and a large number of countries have been forced to do social distancing and lockdown. Lack of targeted therapy continues to be a problem. Epidemiological studies showed that elder patients were more susceptible to severe diseases, while children tend to have milder symptoms. Here we reviewed the current knowledge about this disease and considered the potential explanation of the different symptomatology between children and adults. Elsevier Inc. 2020-06 2020-04-20 /pmc/articles/PMC7169933/ /pubmed/32325252 http://dx.doi.org/10.1016/j.clim.2020.108427 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Yuki, Koichi
Fujiogi, Miho
Koutsogiannaki, Sophia
COVID-19 pathophysiology: A review
title COVID-19 pathophysiology: A review
title_full COVID-19 pathophysiology: A review
title_fullStr COVID-19 pathophysiology: A review
title_full_unstemmed COVID-19 pathophysiology: A review
title_short COVID-19 pathophysiology: A review
title_sort covid-19 pathophysiology: a review
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169933/
https://www.ncbi.nlm.nih.gov/pubmed/32325252
http://dx.doi.org/10.1016/j.clim.2020.108427
work_keys_str_mv AT yukikoichi covid19pathophysiologyareview
AT fujiogimiho covid19pathophysiologyareview
AT koutsogiannakisophia covid19pathophysiologyareview